Molecular modeling and identification of selective estrogen receptor beta agonist for the treatment of Parkinsons disease

dc.contributor.guide	S, Divakar
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Emdormi Rymbai
dc.date.accessioned	2025-02-05T11:37:18Z
dc.date.available	2025-02-05T11:37:18Z
dc.date.awarded	2024
dc.date.completed	2024
dc.date.registered	2020
dc.description.abstract	Available
dc.description.note	Summary 50p, References 52-61p
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-63p
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/620232
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	218
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Parkinson s disease, Estrogen receptor and#946;, Cianidanol, and#945;-Synuclein, Cathepsin D, Nrf2
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Molecular modeling and identification of selective estrogen receptor beta agonist for the treatment of Parkinsons disease
dc.title.alternative
dc.type.degree	Ph.D.